These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 26807792)
1. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats. Zhao T; Sun S; Zhang H; Huang X; Yan M; Dong X; Wen Y; Wang H; Lan HY; Li P PLoS One; 2016; 11(1):e0147693. PubMed ID: 26807792 [TBL] [Abstract][Full Text] [Related]
2. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid. Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437 [TBL] [Abstract][Full Text] [Related]
3. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling. Zhao TT; Zhang HJ; Lu XG; Huang XR; Zhang WK; Wang H; Lan HY; Li P PLoS One; 2014; 9(3):e90807. PubMed ID: 24646636 [TBL] [Abstract][Full Text] [Related]
4. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats. Zhao T; Zhang H; Yin X; Zhao H; Ma L; Yan M; Peng L; Wang Q; Dong X; Li P Biomed Pharmacother; 2020 Sep; 129():110325. PubMed ID: 32535383 [TBL] [Abstract][Full Text] [Related]
5. Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway. Zhang H; Yang Y; Wang Y; Wang B; Li R Drug Des Devel Ther; 2018; 12():89-98. PubMed ID: 29386886 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics. Zhang H; Zhao T; Gong Y; Dong X; Zhang W; Sun S; Wang H; Gu Y; Lu X; Yan M; Li P J Ethnopharmacol; 2014; 151(1):556-64. PubMed ID: 24269779 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Fan XM; Huang CL; Wang YM; Li N; Liang QL; Luo GA J Diabetes Res; 2018; 2018():8237590. PubMed ID: 29682583 [TBL] [Abstract][Full Text] [Related]
8. Renoprotective effect of berberine on type 2 diabetic nephropathy in rats. Sun SF; Zhao TT; Zhang HJ; Huang XR; Zhang WK; Zhang L; Yan MH; Dong X; Wang H; Wen YM; Pan XP; Lan HY; Li P Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):662-70. PubMed ID: 25867602 [TBL] [Abstract][Full Text] [Related]
9. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling. Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016 [TBL] [Abstract][Full Text] [Related]
10. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway. Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381 [TBL] [Abstract][Full Text] [Related]
11. Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling. Xin C; Xia Z; Jiang C; Lin M; Li G Drug Des Devel Ther; 2015; 9():6269-74. PubMed ID: 26664048 [TBL] [Abstract][Full Text] [Related]
12. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways. Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504 [TBL] [Abstract][Full Text] [Related]
13. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells. Xie X; Peng J; Huang K; Huang J; Shen X; Liu P; Huang H Mol Cell Endocrinol; 2012 Oct; 362(1-2):183-93. PubMed ID: 22732364 [TBL] [Abstract][Full Text] [Related]
14. Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression. Zhao H; Li X; Zhao T; Zhang H; Yan M; Dong X; Chen P; Ma L; Li P PLoS One; 2017; 12(2):e0171475. PubMed ID: 28182710 [TBL] [Abstract][Full Text] [Related]
15. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457 [TBL] [Abstract][Full Text] [Related]
16. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway. Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036 [TBL] [Abstract][Full Text] [Related]
17. Calycosin Ameliorates Diabetes-Induced Renal Inflammation via the NF-κB Pathway In Vitro and In Vivo. Zhang YY; Tan RZ; Zhang XQ; Yu Y; Yu C Med Sci Monit; 2019 Mar; 25():1671-1678. PubMed ID: 30830898 [TBL] [Abstract][Full Text] [Related]
18. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway. Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149 [TBL] [Abstract][Full Text] [Related]
19. Effects of combinations of Xiexin decoction constituents on diabetic nephropathy in rats. Wu JS; Liu Y; Shi R; Lu X; Ma YM; Cheng NN J Ethnopharmacol; 2014 Nov; 157():126-33. PubMed ID: 25278183 [TBL] [Abstract][Full Text] [Related]
20. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses. Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]